Showing results (71-80 of 186) with videos related to
Sort By:
Pageof 19
British Journal of Cancer|February 18, 2021
Survival from breast cancer in women with a BRCA2 mutation by treatmentD Gareth Evans, Kelly-Anne Phillips, Roger L Milne, et al.Cancer Causes & Control : CCC|May 30, 2008
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control studyJoanne Kotsopoulos, Clifford L Librach, Jan Lubinski, et al.Gynecologic Oncology|April 9, 2013
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort studyYakir Segev, Javaid Iqbal, Jan Lubinski, et al.Annals of Surgical Oncology|June 7, 2013
International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriersJohn Semple, Kelly A Metcalfe, Henry T Lynch, et al.Cancer Research Communications|November 29, 2023
Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 MutationEmma Guyonnet, Shana J Kim, Yue Yin Xia, et al.Gynecologic Oncology|January 22, 2022
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutationYue Yin Xia, Jacek Gronwald, Beth Karlan, et al.Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.British Journal of Cancer|May 2, 2025
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variantJoanne Kotsopoulos, Christopher A Maxwell, Jan Lubinski, et al.International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.Pageof 19